Login

Financial Snapshot

Revenue
TTM
$1.046B
Gross Margin
TTM
49.17%
Net Income
TTM
-$1.381B
Current Assets
2022 Q4
$709.0M
Current Liabilities
2022 Q4
$389.9M
Current Ratio
2022 Q4
181.84%
Total Assets
2022 Q4
Total Liabilities
2022 Q4
Book Value
2022 Q4
79.50M
Cash
2022 Q4
$176.3M
P/E
Last 4 Quarters
N/A
Free Cash Flow
Last 4 Quarters
N/A

Stock Price

Loading...
Market Cap: $127.29 Million

About Genetron Holdings Ltd

Genetron Holdings Ltd is a CN-based company operating in Biotechnology industry. The company is headquartered in Beijing, Beijing and currently employs 799 full-time employees. The company went IPO on 2020-06-19. Genetron Holdings Limited is a precision oncology company that specializes in cancer molecular profiling and harnesses technologies in molecular biology and data science to transform cancer treatment. The firm has developed a comprehensive product and service portfolio that cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care. The firm operates its businesses primarily within the China market.

Industry: Services-Medical Laboratories Peers: Adagene Inc Fresh2 Group Ltd Burning Rock Biotech Ltd Connect Biopharma Holdings Ltd Gracell Biotechnologies Inc. NovaBridge Biosciences Sinovac Biotech Ltd

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support